Deccan Health Care Statistics
Total Valuation
BOM:542248 has a market cap or net worth of INR 325.15 million. The enterprise value is 325.91 million.
| Market Cap | 325.15M |
| Enterprise Value | 325.91M |
Important Dates
The next estimated earnings date is Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:542248 has 23.43 million shares outstanding. The number of shares has increased by 10.95% in one year.
| Current Share Class | 23.43M |
| Shares Outstanding | 23.43M |
| Shares Change (YoY) | +10.95% |
| Shares Change (QoQ) | +4.19% |
| Owned by Insiders (%) | 47.32% |
| Owned by Institutions (%) | n/a |
| Float | 6.23M |
Valuation Ratios
The trailing PE ratio is 24.72.
| PE Ratio | 24.72 |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.92, with an EV/FCF ratio of -3.42.
| EV / Earnings | 22.97 |
| EV / Sales | 0.38 |
| EV / EBITDA | 8.92 |
| EV / EBIT | 14.85 |
| EV / FCF | -3.42 |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.62 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.54 |
| Debt / FCF | -0.21 |
| Interest Coverage | 11.13 |
Financial Efficiency
Return on equity (ROE) is 1.36% and return on invested capital (ROIC) is 1.47%.
| Return on Equity (ROE) | 1.36% |
| Return on Assets (ROA) | 1.09% |
| Return on Invested Capital (ROIC) | 1.47% |
| Return on Capital Employed (ROCE) | 1.96% |
| Weighted Average Cost of Capital (WACC) | 0.46% |
| Revenue Per Employee | 10.21M |
| Profits Per Employee | 170,952 |
| Employee Count | 83 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.23 |
Taxes
In the past 12 months, BOM:542248 has paid 5.75 million in taxes.
| Income Tax | 5.75M |
| Effective Tax Rate | 28.82% |
Stock Price Statistics
The stock price has decreased by -48.83% in the last 52 weeks. The beta is -0.76, so BOM:542248's price volatility has been lower than the market average.
| Beta (5Y) | -0.76 |
| 52-Week Price Change | -48.83% |
| 50-Day Moving Average | 15.28 |
| 200-Day Moving Average | 18.31 |
| Relative Strength Index (RSI) | 41.30 |
| Average Volume (20 Days) | 17,252 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542248 had revenue of INR 847.12 million and earned 14.19 million in profits. Earnings per share was 0.56.
| Revenue | 847.12M |
| Gross Profit | 290.78M |
| Operating Income | 21.95M |
| Pretax Income | 19.94M |
| Net Income | 14.19M |
| EBITDA | 36.54M |
| EBIT | 21.95M |
| Earnings Per Share (EPS) | 0.56 |
Balance Sheet
The company has 18.87 million in cash and 19.64 million in debt, with a net cash position of -766,000 or -0.03 per share.
| Cash & Cash Equivalents | 18.87M |
| Total Debt | 19.64M |
| Net Cash | -766,000 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 1.09B |
| Book Value Per Share | 44.06 |
| Working Capital | 943.50M |
Cash Flow
In the last 12 months, operating cash flow was -94.24 million and capital expenditures -1.13 million, giving a free cash flow of -95.37 million.
| Operating Cash Flow | -94.24M |
| Capital Expenditures | -1.13M |
| Free Cash Flow | -95.37M |
| FCF Per Share | -4.07 |
Margins
Gross margin is 34.33%, with operating and profit margins of 2.59% and 1.67%.
| Gross Margin | 34.33% |
| Operating Margin | 2.59% |
| Pretax Margin | 2.35% |
| Profit Margin | 1.67% |
| EBITDA Margin | 4.31% |
| EBIT Margin | 2.59% |
| FCF Margin | n/a |
Dividends & Yields
BOM:542248 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.95% |
| Shareholder Yield | -10.95% |
| Earnings Yield | 4.36% |
| FCF Yield | -29.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |